Profile | GDS5420 / 1557380_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 496.5 | 67 |
GSM1296119 | B_lesional_pre-dose | 335.28 | 61 |
GSM1296076 | C_lesional_pre-dose | 235.5 | 57 |
GSM1296092 | D_lesional_pre-dose | 195.84 | 54 |
GSM1296103 | E_lesional_pre-dose | 257.37 | 57 |
GSM1296078 | F_lesional_pre-dose | 224.28 | 56 |
GSM1296107 | G_lesional_pre-dose | 299.19 | 59 |
GSM1296109 | H_lesional_pre-dose | 242.17 | 54 |
GSM1296080 | I_lesional_pre-dose | 412.3 | 65 |
GSM1296090 | J_lesional_pre-dose | 242.24 | 57 |
GSM1296074 | K_lesional_pre-dose | 178.42 | 53 |
GSM1296111 | L_lesional_pre-dose | 393.74 | 63 |
GSM1296099 | M_lesional_pre-dose | 281.92 | 58 |
GSM1296086 | O_lesional_pre-dose | 146.14 | 49 |
GSM1296117 | P_lesional_pre-dose | 221.55 | 53 |
GSM1296113 | Q_lesional_pre-dose | 305.77 | 58 |
GSM1296096 | R_lesional_pre-dose | 473.45 | 67 |
GSM1296105 | S_lesional_pre-dose | 851.92 | 76 |
GSM1296098 | T_lesional_pre-dose | 408.29 | 64 |
GSM1296101 | U_lesional_pre-dose | 518.19 | 68 |
GSM1296121 | V_lesional_pre-dose | 346.87 | 61 |
GSM1296088 | W_lesional_pre-dose | 351.51 | 62 |
GSM1296082 | X_lesional_pre-dose | 194.78 | 54 |
GSM1296115 | Y_lesional_pre-dose | 325.58 | 60 |
GSM1296084 | Z_lesional_pre-dose | 716.27 | 74 |
GSM1296072 | B_lesional_day8 | 514.95 | 68 |
GSM1296069 | L_lesional_day8 | 378.5 | 62 |
GSM1296071 | P_lesional_day8 | 423.98 | 64 |
GSM1296070 | Y_lesional_day8 | 536.4 | 69 |
GSM1296073 | V_lesional_day8 | 316.89 | 60 |
GSM1296034 | A_lesional_day15 | 1378.46 | 85 |
GSM1296041 | G_lesional_day15 | 252.67 | 56 |
GSM1296035 | R_lesional_day15 | 477.5 | 67 |
GSM1296038 | U_lesional_day15 | 382.49 | 63 |
GSM1296047 | B_lesional_day15 | 481.55 | 67 |
GSM1296039 | E_lesional_day15 | 186.24 | 52 |
GSM1296042 | H_lesional_day15 | 297 | 58 |
GSM1296043 | L_lesional_day15 | 465.93 | 66 |
GSM1296037 | M_lesional_day15 | 542.03 | 69 |
GSM1296046 | P_lesional_day15 | 343.75 | 60 |
GSM1296044 | Q_lesional_day15 | 340.81 | 60 |
GSM1296045 | Y_lesional_day15 | 528.09 | 68 |
GSM1296025 | C_lesional_day15 | 932.05 | 78 |
GSM1296033 | D_lesional_day15 | 291.92 | 58 |
GSM1296027 | I_lesional_day15 | 481.33 | 67 |
GSM1296032 | J_lesional_day15 | 680.82 | 73 |
GSM1296024 | K_lesional_day15 | 763.09 | 75 |
GSM1296031 | W_lesional_day15 | 711.17 | 73 |
GSM1296028 | X_lesional_day15 | 489.73 | 67 |
GSM1296029 | Z_lesional_day15 | 836.77 | 76 |
GSM1296026 | F_lesional_day15 | 408.8 | 65 |
GSM1296030 | O_lesional_day15 | 279.06 | 59 |
GSM1296040 | S_lesional_day15 | 543.7 | 69 |
GSM1296036 | T_lesional_day15 | 584.49 | 70 |
GSM1296048 | V_lesional_day15 | 406 | 64 |
GSM1296059 | A_lesional_day43 | 388.73 | 63 |
GSM1296066 | G_lesional_day43 | 346.71 | 61 |
GSM1296060 | R_lesional_day43 | 680.61 | 73 |
GSM1296063 | U_lesional_day43 | 296.02 | 59 |
GSM1296064 | E_lesional_day43 | 266.99 | 58 |
GSM1296067 | H_lesional_day43 | 537.59 | 68 |
GSM1296062 | M_lesional_day43 | 410.47 | 64 |
GSM1296068 | Q_lesional_day43 | 528.26 | 68 |
GSM1296050 | C_lesional_day43 | 568.38 | 70 |
GSM1296057 | D_lesional_day43 | 988.41 | 79 |
GSM1296052 | I_lesional_day43 | 612.91 | 71 |
GSM1296054 | J_lesional_day43 | 767.47 | 75 |
GSM1296049 | K_lesional_day43 | 666.45 | 72 |
GSM1296055 | W_lesional_day43 | 847.59 | 76 |
GSM1296053 | X_lesional_day43 | 949.23 | 78 |
GSM1296058 | Z_lesional_day43 | 906.45 | 77 |
GSM1296051 | F_lesional_day43 | 341.06 | 62 |
GSM1296056 | O_lesional_day43 | 503.92 | 68 |
GSM1296065 | S_lesional_day43 | 608.69 | 71 |
GSM1296061 | T_lesional_day43 | 634.28 | 71 |
GSM1296095 | A_non-lesional_pre-dose | 365.68 | 63 |
GSM1296120 | B_non-lesional_pre-dose | 471.63 | 67 |
GSM1296077 | C_non-lesional_pre-dose | 667.88 | 73 |
GSM1296093 | D_non-lesional_pre-dose | 870.89 | 77 |
GSM1296104 | E_non-lesional_pre-dose | 395.49 | 64 |
GSM1296079 | F_non-lesional_pre-dose | 859.11 | 77 |
GSM1296108 | G_non-lesional_pre-dose | 470.38 | 66 |
GSM1296110 | H_non-lesional_pre-dose | 389.74 | 62 |
GSM1296081 | I_non-lesional_pre-dose | 1045.32 | 79 |
GSM1296091 | J_non-lesional_pre-dose | 332.69 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 292.27 | 60 |
GSM1296112 | L_non-lesional_pre-dose | 784.99 | 75 |
GSM1296100 | M_non-lesional_pre-dose | 754.59 | 74 |
GSM1296087 | O_non-lesional_pre-dose | 532.05 | 69 |
GSM1296118 | P_non-lesional_pre-dose | 416.47 | 64 |
GSM1296114 | Q_non-lesional_pre-dose | 454.33 | 66 |
GSM1296097 | R_non-lesional_pre-dose | 813.98 | 76 |
GSM1296106 | S_non-lesional_pre-dose | 1007.76 | 79 |
GSM1296102 | U_non-lesional_pre-dose | 718.41 | 73 |
GSM1296122 | V_non-lesional_pre-dose | 854.5 | 77 |
GSM1296089 | W_non-lesional_pre-dose | 748.6 | 74 |
GSM1296083 | X_non-lesional_pre-dose | 1488.39 | 85 |
GSM1296116 | Y_non-lesional_pre-dose | 704.57 | 73 |
GSM1296085 | Z_non-lesional_pre-dose | 790.09 | 75 |